SCHEMBL3957941

SCHEMBL3957941

CCCCC(=O)N1CCOC1=O

nearest known ligand 0.87

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 15/20 0.87
FAAH O00519 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28172997 0.95 NAAA (0.79) NAAAFAAH
SCHEMBL22953486 0.95 NAAA (0.97) NAAAFAAH
SCHEMBL8156788 0.93 NAAA (1.00) NAAAFAAH
SCHEMBL7698014 0.93 NAAA (1.00) NAAAFAAH
SCHEMBL8149956 0.93 NAAA (1.00) NAAAFAAH
SCHEMBL19612753 0.93 NAAA (1.00) NAAAFAAH
SCHEMBL8157214 0.93 NAAA (1.00) NAAAFAAH
Benzene SCHEMBL27992481 0.90 NAAA (0.88) NAAAFAAH
SCHEMBL12999946 0.89 NAAA (0.75) NAAAFAAH
Benzene SCHEMBL28173853 0.89 NAAA (0.91) NAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543229-B1 METHOD FOR PREPARING OPTICALLY PURE (R)-4-N-PROPYL-DIHYDROFURAN-2(3H)-ONE BEIJING ABLEPHARMTECH CO LTD (CN) 2021-04-14 EP disclosed
EP-3543229-A1 METHOD FOR PREPARING OPTICALLY PURE (R)-4-N-PROPYL-DIHYDROFURAN-2(3H)-ONE Beijing AblePharmtech Co., Ltd. (CN) 2019-09-25 EP disclosed
CN-105693649-B A kind of preparation method of posaconazole intermediate 重庆圣华曦药业股份有限公司 2018-01-19 CN disclosed
CN-104356082-B One class substituted heterocycle derivant and preparation method thereof 厦门大学 2016-07-13 CN disclosed
CN-105693649-A Method for preparing posaconazole intermediate 重庆圣华曦药业股份有限公司 2016-06-22 CN disclosed
EP-1047425-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-04-22 EP disclosed
EP-1047425-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-11-02 EP disclosed
WO-1999030709-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1999-06-24 WO disclosed